Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 12
143
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparative study on inhibitory effects of ginsenosides on human pancreatic lipase and porcine pancreatic lipase: structure-activity relationships and inhibitory mechanism

, , , , &
Pages 2031-2039 | Received 25 Mar 2023, Accepted 03 Jul 2023, Published online: 20 Jul 2023

References

  • Bessesen DH, Van Gaal LF. 2018. Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes Endocrinol. 6(3):237–248. doi:10.1016/S2213-8587(17)30236-X.
  • Caballero B. 2019. Humans against Obesity: who Will Win? Adv Nutr. 10(suppl_1):S4–S9. doi:10.1093/advances/nmy055.
  • Chen W, Balan P, Popovich DG. 2019. Analysis of ginsenoside content (Panax ginseng) from different regions. Molecules. 24(19):3491. doi:10.3390/molecules24193491.
  • Gao Y, Li J, Wang J, Li X, Li J, Chu S, Li L, Chen N, Zhang L, 2020. Ginsenoside Rg1 prevent and treat inflammatory diseases: a review. Int Immunopharmacol. 87:106805. doi:10.1016/j.intimp.2020.106805.
  • Hou X-D, Guan X-Q, Cao Y-F, Weng Z-M, Hu Q, Liu H-B, Jia S-N, Zang S-Z, Zhou Q, Yang L, et al. 2020. Inhibition of pancreatic lipase by the constituents in St. John’s Wort: in vitro. Int J Biol Macromol. 145:620–633. doi:10.1016/j.ijbiomac.2019.12.231.
  • Hou X-D, Qin X-Y, Hou J, Tang H, Ge G-B, 2022. The potential of natural sources for pancreatic lipase inhibitors: a solution of the obesity crisis? Expert Opin Drug Discov. 17(12):1295–1298. doi:10.1080/17460441.2023.2156499.
  • Hou X-D, Song L-L, Cao Y-F, Wang Y-N, Zhou Q, Fang S-Q, Wu D-C, Zang S-Z, Chen L, Bai Y, et al. 2020. Pancreatic lipase inhibitory constituents from Fructus Psoraleae. Chin J Nat Med. 18(5):369–378. doi:10.1016/S1875-5364(20)30043-1.
  • Jin Q, Song L-L, Ding L-L, Zhang J, Wang D-D, Song Y-Q, Zou L-W, Ge G-B, 2022. High-throughput optical assays for sensing serine hydrolases in living systems and their applications. TrAC, Trends Anal Chem. 152:116620. doi:10.1016/j.trac.2022.116620.
  • Li L, Pan C-S, Yan L, Cui Y-C, Liu Y-Y, Mu H-N, He K, Hu B-H, Chang X, Sun K, et al. 2018. Ginsenoside Rg1 ameliorates rat myocardial ischemia-reperfusion injury by modulating energy metabolism pathways. Front Physiol. 9:78. doi:10.3389/fphys.2018.00078.
  • Li ZP, Ji G. 2017. Effects of various ginsenosides and ginseng root and ginseng berry on the activity of Pancreatic lipase. Food Sci Biotechnol. 26(3):767–773. doi:10.1007/s10068-017-0090-6.
  • Liu J, Wang Y, Lin L. 2019. Small molecules for fat combustion: targeting obesity. Acta Pharm Sin B. 9(2):220–236. doi:10.1016/j.apsb.2018.09.007.
  • Liu JH, Dong Q, Du G, et al. 2022. Identification of metabolites in plasma related to different biological activities of Panax ginseng and American ginseng. Rapid Commun Mass Spectrom. 36(4):e9219.
  • Liu P-K, Weng Z-M, Ge G-B, Li H-L, Ding L-L, Dai Z-R, Hou X-D, Leng Y-H, Yu Y, Hou J, et al. 2018. Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: inhibition potentials and mechanism. Int J Biol Macromol. 118(Pt B):2216–2223. doi:10.1016/j.ijbiomac.2018.07.085.
  • Liu Y, Zhang H, Dai X, Zhu R, Chen B, Xia B, Ye Z, Zhao D, Gao S, Orekhov AN, et al. 2021. A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng. Phytomedicine. 92:153717. doi:10.1016/j.phymed.2021.153717.
  • Ma L-J, Hou X-D, Qin X-Y, He R-J, Yu H-N, Hu Q, Guan X-Q, Jia S-N, Hou J, Lei T, et al. 2022. Discovery of human pancreatic lipase inhibitors from root of Rhodiola crenulata via integrating bioactivity-guided fractionation, chemical profiling and biochemical assay. J Pharm Anal. 12(4):683–691. doi:10.1016/j.jpha.2022.04.002.
  • Motamed N, Rabiee B, Roozafzai F, Zamani F, Faraji AH, Maadi M, Keyvani H, Khonsari MR, Hemasi GR, 2018. Metabolic syndrome and cardiovascular risk assessment tools’ estimations of 10-year cardiovascular risk: a population-based study. Acta Cardiol. 73(5):439–446. doi:10.1080/00015385.2017.1410335.
  • Petrie JR, Guzik TJ, Touyz RM. 2018. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 34(5):575–584. doi:10.1016/j.cjca.2017.12.005.
  • Point V, Pavan Kumar KVP, Marc S, Delorme V, Parsiegla G, Amara S, Carrière F, Buono G, Fotiadu F, Canaan S, et al. 2012. Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones. Eur J Med Chem. 58:452–463. doi:10.1016/j.ejmech.2012.10.040.
  • Sun Z-H, Chen J, Song Y-Q, Dou T-Y, Zou L-W, Hao D-C, Liu H-B, Ge G-B, Yang L 2019. Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism. Chin Med. 14(1):56.
  • Zhang J, Pan Q-S, Qian X-K, Zhou X-L, Wang Y-J, He R-J, Wang L-T, Li Y-R, Huo H, Sun C-G, et al. 2022. Discovery of triterpenoids as potent dual inhibitors of pancreatic lipase and human carboxylesterase 1. J Enzyme Inhib Med Chem. 37(1):629–640. doi:10.1080/14756366.2022.2029855.
  • Zhang J, Yang Y, Qian X-K, Song P-F, Zhao Y-S, Guan X-Q, Zou L-W, Bao X, Wang H, 2021. Design, synthesis, and structure-activity relationship study of pyrazolones as potent inhibitors of pancreatic lipase. ChemMedChem. 16(10):1600–1604. doi:10.1002/cmdc.202000850.
  • Zhao C, Sun R, Cao B, Gu S, Zhao J, Liu L, Wang X, Zha W, Yu X, Xiao W, et al. 2014. An in vitro metabolic system of gut flora and the metabolism of ginsenoside Rg3. Eur J Drug Metab Pharmacokinet. 39(2):129–137. doi:10.1007/s13318-013-0143-z.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.